sameAs
Strong induction of p73 protein in vivo coincides with the onset of apoptosis in rat liver after treatment with the hepatocarcinogen N-nitrosomorpholine (NNM)Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1.Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells.Antinuclear antibodies in primary biliary cirrhosis.The subcellular distribution of the p53 tumour suppressor, and organismal ageing.Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein.Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?Central and carboxy-terminal regions of human p53 protein are essential for interaction and complex formation with PARP-1.Tubulohelical membrane arrays: From the initial observation to the elucidation of nanophysical properties and cellular function.Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine.p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells.Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells.A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: up-regulation of CLIMP-63, a cytoskeleton-linking membrane protein.Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest.Effect of distinct anticancer drugs on the phosphorylation of p53 protein at serine 46 in human MCF-7 breast cancer cells.Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen.Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine.Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells.Phenol red reduces ROSC mediated cell cycle arrest and apoptosis in human MCF-7 cells.Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
P50
Q28578883-8639FC73-7612-4F7D-95AA-A298244E3ED0Q33188002-9B3A8602-70A5-48DC-B727-6566D1AEBA38Q33292475-B70BF614-4B30-46B6-9F13-AEDB20D956C3Q34385665-CAAA3463-02E8-484E-B57D-D6DAF6421DCCQ34448645-69B6D83B-8BF8-4E1E-9CCA-00624AA776EFQ36283096-F148952A-7D04-4D23-BB6F-7843E1F8B9A4Q36349640-A7EF9115-64AF-40C9-821B-2D2306D34820Q36604805-D9044B43-58AA-4FF2-B05C-5902F5694E64Q36807560-37B44B78-16FE-4C0C-A532-5906666B6D8EQ37590388-9C5F969B-67FB-410C-9CCD-3A2F1B873777Q38355401-B654FEA9-8B71-4917-8055-CB7FE383B4ACQ39687525-7FD7874A-16FB-4BF6-A025-EA36477CB846Q39804992-5CF3CB35-20D2-4209-B23C-4E322237464DQ39869069-6BC8DF58-36E2-468F-BA66-F7CFA540D4C8Q39890812-0A780A92-4DA7-452C-877B-764572A89476Q39930544-C3851EDF-377E-44EB-8161-B92E34CD2C75Q39944973-2A2A4716-85DE-47B6-BC86-DF4B062955E6Q40058850-A0EDBDEB-91CA-4C94-AA23-7587D1392706Q40068590-69493673-2C57-4E39-A0AD-D281273F3FE9Q40148351-38F796CE-F631-4F71-9E2B-E5B7F8CA2346Q40150740-9AA01DDB-5510-4EDA-B0AA-E1DFC81461B1Q40160651-07B75999-AD9D-4D00-A14D-4188AAC7B56DQ40181461-AE659EF5-44A6-4AFE-8D31-5A40DF9C071BQ40186775-DCBF684D-D0ED-4B18-AE3B-057F6319205CQ40272214-D1A6EF26-F3BF-4630-9D99-AE213BB11F90Q40602495-82FEB4B0-2ED7-4FD3-A29A-AD2938A1E07B
P50
description
onderzoeker
@nl
profesor, doktor habilitowana nauk biologicznych, biochemik
@pl
name
Józefa Gądek-Węsierski
@pl
Józefa Wesierska-Gadek
@ast
Józefa Wesierska-Gadek
@en
Józefa Wesierska-Gadek
@es
Józefa Wesierska-Gadek
@sl
type
label
Józefa Gądek-Węsierski
@pl
Józefa Wesierska-Gadek
@ast
Józefa Wesierska-Gadek
@en
Józefa Wesierska-Gadek
@es
Józefa Wesierska-Gadek
@sl
altLabel
Józefa Gądek-Węsierski
@en
prefLabel
Józefa Gądek-Węsierski
@pl
Józefa Wesierska-Gadek
@ast
Józefa Wesierska-Gadek
@en
Józefa Wesierska-Gadek
@es
Józefa Wesierska-Gadek
@sl
P1559
Józefa Gądek-Węsierski
@pl
P19
P21
P214
249144782708914501582
P31
P3124
P569
1951-03-14T00:00:00Z
P7293
9810573258605606
P735
P7859
viaf-249144782708914501582